200 related articles for article (PubMed ID: 16863471)
1. Genomic-based biomarkers of drug-induced nephrotoxicity.
Davis JW; Kramer JA
Expert Opin Drug Metab Toxicol; 2006 Feb; 2(1):95-101. PubMed ID: 16863471
[TBL] [Abstract][Full Text] [Related]
2. Genomic and proteomic profiling for biomarkers and signature profiles of toxicity.
Merrick BA; Bruno ME
Curr Opin Mol Ther; 2004 Dec; 6(6):600-7. PubMed ID: 15663324
[TBL] [Abstract][Full Text] [Related]
3. Advances in toxicogenomics.
Hayes KR; Bradfield CA
Chem Res Toxicol; 2005 Mar; 18(3):403-14. PubMed ID: 15777080
[No Abstract] [Full Text] [Related]
4. Toxicogenomics in drug discovery and development -- making an impact.
Wills Q; Mitchell C
Altern Lab Anim; 2009 Sep; 37 Suppl 1():33-7. PubMed ID: 19807202
[TBL] [Abstract][Full Text] [Related]
5. Use of transcriptomics in understanding mechanisms of drug-induced toxicity.
Cui Y; Paules RS
Pharmacogenomics; 2010 Apr; 11(4):573-85. PubMed ID: 20350139
[TBL] [Abstract][Full Text] [Related]
6. Identification and measurement of genomic biomarkers of nephrotoxicity.
Goodsaid FM
J Pharmacol Toxicol Methods; 2004; 49(3):183-6. PubMed ID: 15172014
[TBL] [Abstract][Full Text] [Related]
7. Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers.
Pallet N; Djamali A; Legendre C
Pharmacol Res; 2011 Jul; 64(1):25-30. PubMed ID: 21473913
[TBL] [Abstract][Full Text] [Related]
8. Iconix Biosciences, Inc.
Fielden MR; Halbert DN
Pharmacogenomics; 2007 Apr; 8(4):401-5. PubMed ID: 17391077
[TBL] [Abstract][Full Text] [Related]
9. Future of toxicogenomics and safety signatures: balancing public access to data with proprietary drug discovery.
Fostel JM
Pharmacogenomics; 2007 May; 8(5):425-30. PubMed ID: 17465705
[No Abstract] [Full Text] [Related]
10. Current and future use of genomics data in toxicology: opportunities and challenges for regulatory applications.
Goetz AK; Singh BP; Battalora M; Breier JM; Bailey JP; Chukwudebe AC; Janus ER
Regul Toxicol Pharmacol; 2011 Nov; 61(2):141-53. PubMed ID: 21840362
[TBL] [Abstract][Full Text] [Related]
11. Identification of genomic biomarkers for concurrent diagnosis of drug-induced renal tubular injury using a large-scale toxicogenomics database.
Kondo C; Minowa Y; Uehara T; Okuno Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
Toxicology; 2009 Nov; 265(1-2):15-26. PubMed ID: 19761811
[TBL] [Abstract][Full Text] [Related]
12. State-of-the-art genomics approaches in toxicology.
Van Hummelen P; Sasaki J
Mutat Res; 2010 Dec; 705(3):165-71. PubMed ID: 20466069
[TBL] [Abstract][Full Text] [Related]
13. Validation of putative genomic biomarkers of nephrotoxicity in rats.
Wang EJ; Snyder RD; Fielden MR; Smith RJ; Gu YZ
Toxicology; 2008 Apr; 246(2-3):91-100. PubMed ID: 18289764
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomics in drug development.
Guerreiro N; Staedtler F; Grenet O; Kehren J; Chibout SD
Toxicol Pathol; 2003; 31(5):471-9. PubMed ID: 14692614
[TBL] [Abstract][Full Text] [Related]
15. Toxicogenomics: a pivotal piece in the puzzle of toxicological research.
Gatzidou ET; Zira AN; Theocharis SE
J Appl Toxicol; 2007; 27(4):302-9. PubMed ID: 17429800
[TBL] [Abstract][Full Text] [Related]
16. The introduction of toxicogenomics; potential new markers of hepatotoxicity.
Heijne WH; Stierum RH; Leeman WR; van Ommen B
Cancer Biomark; 2005; 1(1):41-57. PubMed ID: 17192031
[No Abstract] [Full Text] [Related]
17. Toxicogenomic biomarkers for renal papillary injury in rats.
Uehara T; Kondo C; Morikawa Y; Hanafusa H; Ueda S; Minowa Y; Nakatsu N; Ono A; Maruyama T; Kato I; Yamate J; Yamada H; Ohno Y; Urushidani T
Toxicology; 2013 Jan; 303():1-8. PubMed ID: 23142791
[TBL] [Abstract][Full Text] [Related]
18. Immunotoxicogenomics: the potential of genomics technology in the immunotoxicity risk assessment process.
Luebke RW; Holsapple MP; Ladics GS; Luster MI; Selgrade M; Smialowicz RJ; Woolhiser MR; Germolec DR
Toxicol Sci; 2006 Nov; 94(1):22-7. PubMed ID: 16882865
[TBL] [Abstract][Full Text] [Related]
19. Application of toxicogenomics in drug development.
Gant TW
Drug News Perspect; 2003 May; 16(4):217-21. PubMed ID: 12942151
[TBL] [Abstract][Full Text] [Related]
20. Genomics and the search for novel biomarkers in toxicology.
Tugwood JD; Hollins LE; Cockerill MJ
Biomarkers; 2003; 8(2):79-92. PubMed ID: 12775494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
